Tiziana Life Sciences
TLSA
•
NASDAQ
•
| 52W Range | $0.62-$2.60 |
| Market Cap | $211.4M |
| Shares Short | 657,243 |
| Revenue (12 Mos) | -$3.5M |
| Revenue Growth (YoY) | 0% |
| Gross Profit (12 Mos) | $0 |
| Diluted EPS | -$0.11 |
Yahoo Finance • 19 days ago
Yahoo Finance • 2 months ago
Yahoo Finance • 3 months ago
Yahoo Finance • 3 months ago
| CEO | Dr. Ivor R. Elrifi Ph.D. |
| CFO | Ms. Keeren Shah |
| Address | 14/15 Conduit Street, London, United Kingdom, W1S 2XJ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Full-Time Employees | 9 |